Skip to content

Bismuth subnitrate

ALIMENTARY TRACT AND METABOLISM

ATC A02BX12

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Bismuth subnitrate is a drug catalogued in DrugCentral.

  • ATC code: A02BX12 (Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)).
  • Molecular formula: Bi5H9N4O22; molecular weight 1461.98 g/mol.

ATC classification

ATC codeTherapeutic hierarchy
A02BX12ALIMENTARY TRACT AND METABOLISM › DRUGS FOR ACID RELATED DISORDERS › DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) › Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Myasthenia gravis247.3
Hyperphosphataemia213.0
Activated partial thromboplastin time prolonged181.9
Congenital hiatus hernia181.5
Analgesic therapy181.3
Drug therapy175.6
Appendicolith175.3
Sleep disorder therapy169.5
Hypophosphataemia169.2
Anticoagulant therapy166.4
Antacid therapy165.9
Neuralgia147.5

Chemical structure

Molecular formulaBi5H9N4O22
Molecular weight1461.98 g/mol
CAS number1304-85-4
InChIKey—
PubChem CID73415757

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is the chemical formula of Bismuth subnitrate?

Bismuth subnitrate has the molecular formula Bi5H9N4O22 and a molecular weight of 1461.98 g/mol.

Browse: all drugs starting with B · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets0
Indications0
FormulaBi5H9N4O22
DrugCentral ID4841
Interactive profile